Testing effectiveness (Phase 2)Study completedNCT00019955
What this trial is testing
Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)
Who this might be right for
Kidney Cancer
National Cancer Institute (NCI)